0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Insulin Glargine Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-2316
Home | Market Reports | Health | Health Conditions | Endocrine Conditions
Global Insulin Glargine Market Insights Forecast to 2025

Global Insulin Glargine Market Insights, Forecast to 2025

Code: QYRE-Auto-2316
Report
May 2019
117 Pages
QYResearch
Region: Global, China, India, North America, Japan,
Description
Table of Content
Tables & Figures
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
Insulin glargine is a long-acting, man-made version of human insulin. Insulin glargine works by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is Used for energy. It also stops the liver from producing more sugar. There are two type of Insulin glargine, which are Single Dose Vial and Pre-filled Syringe in the market. Considering its function, Insulin glargine is Used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also Used to treat people with type 2 diabetes (condition in which the body does not Used insulin normally and, therefore, cannot control the amount of sugar in the blood) who need insulin to control their diabetes. We can see that there are just a few companies produce Insulin glargine, the production of them almost approach to 70% of whole market. They have seted plant in Japan, China, German, India, North Americato produce Insulin glargine, and China is the largest plant for Insulin glargine in the world and also the largest consumption country. As the amount of diabetes of increasing of China, the Chinese market will be bigger than North America. The Industry is affected by the economic development level and policy, so it’s important to put an eye to economic indexes and leaders’ prefer. With the global economic recovery, more and more people pay attention to care about personal health, especially in underdevelopment regions that have a large population and fast economic growth, the need of Insulin glargine will increase.
The global Insulin Glargine market is valued at 5690 million US$ in 2018 and will reach 7780 million US$ by the end of 2025, growing at a CAGR of 4.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Insulin Glargine market based on company, product type, end user and key regions.

This report studies the global market size of Insulin Glargine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insulin Glargine in these regions.
This research report categorizes the global Insulin Glargine market by top players/brands, region, type and end user. This report also studies the global Insulin Glargine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Sanofi-Aventis
    Ganlee
    Biocon

Market size by Product
    Single Dose Vial
    Pre-filled Syringe
Market size by End User
    Treat type2 diabetes
    Treat type1 diabetes

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Insulin Glargine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Insulin Glargine market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Insulin Glargine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Insulin Glargine submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Insulin Glargine are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M mL). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Insulin Glargine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1 Insulin Glargine Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Insulin Glargine Market Size Growth Rate by Product
        1.4.2 Single Dose Vial
        1.4.3 Pre-filled Syringe
    1.5 Market by End User
        1.5.1 Global Insulin Glargine Market Size Growth Rate by End User
        1.5.2 Treat type2 diabetes
        1.5.3 Treat type1 diabetes
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Insulin Glargine Market Size
        2.1.1 Global Insulin Glargine Revenue 2014-2025
        2.1.2 Global Insulin Glargine Sales 2014-2025
    2.2 Insulin Glargine Growth Rate by Regions
        2.2.1 Global Insulin Glargine Sales by Regions
        2.2.2 Global Insulin Glargine Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Insulin Glargine Sales by Manufacturers
        3.1.1 Insulin Glargine Sales by Manufacturers
        3.1.2 Insulin Glargine Sales Market Share by Manufacturers
        3.1.3 Global Insulin Glargine Market Concentration Ratio (CR5 and HHI)
    3.2 Insulin Glargine Revenue by Manufacturers
        3.2.1 Insulin Glargine Revenue by Manufacturers (2014-2019)
        3.2.2 Insulin Glargine Revenue Share by Manufacturers (2014-2019)
    3.3 Insulin Glargine Price by Manufacturers
    3.4 Insulin Glargine Manufacturing Base Distribution, Product Types
        3.4.1 Insulin Glargine Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Insulin Glargine Product Type
        3.4.3 Date of International Manufacturers Enter into Insulin Glargine Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Insulin Glargine Sales by Product
    4.2 Global Insulin Glargine Revenue by Product
    4.3 Insulin Glargine Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Insulin Glargine Breakdown Data by End User

6 North America
    6.1 North America Insulin Glargine by Countries
        6.1.1 North America Insulin Glargine Sales by Countries
        6.1.2 North America Insulin Glargine Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Insulin Glargine by Product
    6.3 North America Insulin Glargine by End User

7 Europe
    7.1 Europe Insulin Glargine by Countries
        7.1.1 Europe Insulin Glargine Sales by Countries
        7.1.2 Europe Insulin Glargine Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Insulin Glargine by Product
    7.3 Europe Insulin Glargine by End User

8 Asia Pacific
    8.1 Asia Pacific Insulin Glargine by Countries
        8.1.1 Asia Pacific Insulin Glargine Sales by Countries
        8.1.2 Asia Pacific Insulin Glargine Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Insulin Glargine by Product
    8.3 Asia Pacific Insulin Glargine by End User

9 Central & South America
    9.1 Central & South America Insulin Glargine by Countries
        9.1.1 Central & South America Insulin Glargine Sales by Countries
        9.1.2 Central & South America Insulin Glargine Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Insulin Glargine by Product
    9.3 Central & South America Insulin Glargine by End User

10 Middle East and Africa
    10.1 Middle East and Africa Insulin Glargine by Countries
        10.1.1 Middle East and Africa Insulin Glargine Sales by Countries
        10.1.2 Middle East and Africa Insulin Glargine Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Insulin Glargine by Product
    10.3 Middle East and Africa Insulin Glargine by End User

11 Company Profiles
    11.1 Sanofi-Aventis
        11.1.1 Sanofi-Aventis Company Details
        11.1.2 Company Business Overview
        11.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Sanofi-Aventis Insulin Glargine Products Offered
        11.1.5 Sanofi-Aventis Recent Development
    11.2 Ganlee
        11.2.1 Ganlee Company Details
        11.2.2 Company Business Overview
        11.2.3 Ganlee Insulin Glargine Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Ganlee Insulin Glargine Products Offered
        11.2.5 Ganlee Recent Development
    11.3 Biocon
        11.3.1 Biocon Company Details
        11.3.2 Company Business Overview
        11.3.3 Biocon Insulin Glargine Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Biocon Insulin Glargine Products Offered
        11.3.5 Biocon Recent Development

12 Future Forecast
    12.1 Insulin Glargine Market Forecast by Regions
        12.1.1 Global Insulin Glargine Sales Forecast by Regions 2019-2025
        12.1.2 Global Insulin Glargine Revenue Forecast by Regions 2019-2025
    12.2 Insulin Glargine Market Forecast by Product
        12.2.1 Global Insulin Glargine Sales Forecast by Product 2019-2025
        12.2.2 Global Insulin Glargine Revenue Forecast by Product 2019-2025
    12.3 Insulin Glargine Market Forecast by End User
    12.4 North America Insulin Glargine Forecast
    12.5 Europe Insulin Glargine Forecast
    12.6 Asia Pacific Insulin Glargine Forecast
    12.7 Central & South America Insulin Glargine Forecast
    12.8 Middle East and Africa Insulin Glargine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Insulin Glargine Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures

    Figure Insulin Glargine Product Picture
    Table Insulin Glargine Market Segments
    Table Key Manufacturers Insulin Glargine Covered
    Table Global Insulin Glargine Market Size Growth Rate by Product 2019-2025 (M mL) & (Million US$)
    Figure Global Insulin Glargine Sales Market Share by Product 2014-2025
    Figure Single Dose Vial Product Picture
    Table Major Manufacturers of Single Dose Vial
    Figure Pre-filled Syringe Product Picture
    Table Major Manufacturers of Pre-filled Syringe
    Table Global Insulin Glargine Market Size Growth Rate by End User 2019-2025 (M mL)
    Figure Treat type2 diabetes
    Figure Treat type1 diabetes
    Figure Insulin Glargine Report Years Considered
    Figure Global Insulin Glargine Market Size 2014-2025 (Million US$)
    Figure Global Insulin Glargine Sales 2014-2025 (M mL)
    Table Global Insulin Glargine Market Size by Regions 2014-2019 (M mL) & (Million US$)
    Table Global Insulin Glargine Sales by Regions 2014-2019 (M mL)
    Table Global Insulin Glargine Sales Market Share by Regions 2014-2019
    Figure Global Insulin Glargine Sales Market Share by Regions 2014-2019
    Figure 2018 Global Insulin Glargine Sales Market Share by Regions
    Table Global Insulin Glargine Revenue by Regions 2014-2019 (Million US$)
    Table Global Insulin Glargine Revenue Market Share by Regions 2014-2019
    Figure Global Insulin Glargine Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Insulin Glargine Revenue Market Share by Regions
    Table Global Insulin Glargine Sales by Manufacturers (2014-2019) (M mL)
    Table Global Insulin Glargine Sales Share by Manufacturers (2014-2019)
    Figure Global Insulin Glargine Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Insulin Glargine Revenue by Manufacturers (2014-2019) (Million USD)
    Table Insulin Glargine Revenue Share by Manufacturers (2014-2019)
    Figure Insulin Glargine Value Share by Manufacturers in 2018
    Table Key Manufacturers Insulin Glargine Price (2014-2019) (USD/Ml)
    Table Insulin Glargine Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Insulin Glargine Product Type
    Table Date of International Manufacturers Enter into Insulin Glargine Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Insulin Glargine Sales by Product (2014-2019) (M mL)
    Table Global Insulin Glargine Sales Share by Product (2014-2019)
    Figure Global Insulin Glargine Sales Market Share by Product (2014-2019)
    Figure Global Insulin Glargine Sales Market Share by Product in 2018
    Table Global Insulin Glargine Revenue by Product (2014-2019) (Million US$)
    Table Global Insulin Glargine Revenue Share by Product (2014-2019)
    Figure Global Insulin Glargine Revenue Market Share by Product (2014-2019)
    Figure Global Insulin Glargine Revenue Market Share by Product in 2018
    Table Insulin Glargine Price by Product 2014-2019 (USD/Ml)
    Table Global Insulin Glargine Sales by End User (2014-2019) (M mL)
    Table Global Insulin Glargine Sales Share by End User (2014-2019)
    Figure Global Sales Insulin Glargine Market Share by End User (2014-2019)
    Figure Global Sales Insulin Glargine Market Share by End User in 2018
    Figure North America Insulin Glargine Sales Growth Rate 2014-2019 (M mL)
    Figure North America Insulin Glargine Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Insulin Glargine Sales by Countries (2014-2019) (M mL)
    Table North America Insulin Glargine Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Insulin Glargine Sales Market Share by Countries
    Table North America Insulin Glargine Revenue by Countries (2014-2019) (Million US$)
    Table North America Insulin Glargine Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Insulin Glargine Revenue Market Share by Countries
    Figure United States Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure United States Insulin Glargine Revenue Growth Rate (2014-2019) (M mL)
    Figure Canada Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Canada Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Mexico Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Insulin Glargine Sales by Product (2014-2019) (M mL)
    Table North America Insulin Glargine Sales Market Share by Product (2014-2019)
    Figure 2018 North America Insulin Glargine Market Share by Product
    Table North America Insulin Glargine Sales by End User (2014-2019) (M mL)
    Table North America Insulin Glargine Sales Market Share by End User (2014-2019)
    Figure 2018 North America Insulin Glargine Market Share by End User
    Figure Europe Insulin Glargine Sales Growth Rate 2014-2019 (M mL)
    Figure Europe Insulin Glargine Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Insulin Glargine Sales by Countries (2014-2019) (M mL)
    Table Europe Insulin Glargine Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Insulin Glargine Sales Market Share by Countries
    Table Europe Insulin Glargine Revenue by Countries (2014-2019) (Million US$)
    Table Europe Insulin Glargine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Insulin Glargine Revenue Market Share by Countries
    Figure Germany Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Germany Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure France Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure UK Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Italy Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Russia Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Insulin Glargine Sales by Product (2014-2019) (M mL)
    Table Europe Insulin Glargine Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Insulin Glargine Market Share by Product
    Table Europe Insulin Glargine Sales by End User (2014-2019) (M mL)
    Table Europe Insulin Glargine Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Insulin Glargine Market Share by End User
    Figure Asia Pacific Insulin Glargine Sales Growth Rate 2014-2019 (M mL)
    Figure Asia Pacific Insulin Glargine Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Insulin Glargine Sales by Countries (2014-2019) (M mL)
    Table Asia Pacific Insulin Glargine Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Insulin Glargine Sales Market Share by Countries
    Table Asia Pacific Insulin Glargine Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Insulin Glargine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Insulin Glargine Revenue Market Share by Countries
    Figure China Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure China Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Japan Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Korea Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure India Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Australia Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Indonesia Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Malaysia Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Philippines Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Thailand Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Vietnam Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Singapore Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Insulin Glargine Sales by Product (2014-2019) (M mL)
    Table Asia Pacific Insulin Glargine Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Insulin Glargine Market Share by Product
    Table Asia Pacific Insulin Glargine Sales by End User (2014-2019) (M mL)
    Table Asia Pacific Insulin Glargine Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Insulin Glargine Market Share by End User
    Figure Central & South America Insulin Glargine Sales Growth Rate 2014-2019 (M mL)
    Figure Central & South America Insulin Glargine Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Insulin Glargine Sales by Countries (2014-2019) (M mL)
    Table Central & South America Insulin Glargine Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Insulin Glargine Sales Market Share by Countries
    Table Central & South America Insulin Glargine Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Insulin Glargine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Insulin Glargine Revenue Market Share by Countries
    Figure Brazil Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Brazil Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Argentina Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Insulin Glargine Sales by Product (2014-2019) (M mL)
    Table Central & South America Insulin Glargine Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Insulin Glargine Market Share by Product
    Table Central & South America Insulin Glargine Sales by End User (2014-2019) (M mL)
    Table Central & South America Insulin Glargine Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Insulin Glargine Market Share by End User
    Figure Middle East and Africa Insulin Glargine Sales Growth Rate 2014-2019 (M mL)
    Figure Middle East and Africa Insulin Glargine Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Insulin Glargine Sales by Countries (2014-2019) (M mL)
    Table Middle East and Africa Insulin Glargine Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Insulin Glargine Sales Market Share by Countries
    Table Middle East and Africa Insulin Glargine Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Insulin Glargine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Insulin Glargine Revenue Market Share by Countries
    Figure GCC Countries Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure GCC Countries Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Turkey Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure Egypt Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Insulin Glargine Sales Growth Rate (2014-2019) (M mL)
    Figure South Africa Insulin Glargine Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Insulin Glargine Sales by Product (2014-2019) (M mL)
    Table Middle East and Africa Insulin Glargine Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Insulin Glargine Market Share by Product
    Table Middle East and Africa Insulin Glargine Sales by End User (2014-2019) (M mL)
    Table Middle East and Africa Insulin Glargine Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Insulin Glargine Market Share by End User
    Table Sanofi-Aventis Company Details
    Table Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/Ml) and Gross Margin (2014-2019)
    Table Sanofi-Aventis Recent Development
    Table Ganlee Company Details
    Table Ganlee Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/Ml) and Gross Margin (2014-2019)
    Table Ganlee Recent Development
    Table Biocon Company Details
    Table Biocon Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/Ml) and Gross Margin (2014-2019)
    Table Biocon Recent Development
    Table Global Insulin Glargine Sales Forecast by Regions 2019-2025 (M mL)
    Table Global Insulin Glargine Sales Market Share Forecast by Regions 2019-2025
    Table Global Insulin Glargine Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Insulin Glargine Revenue Market Share Forecast by Regions 2019-2025
    Table Global Insulin Glargine Sales Forecast by Product 2019-2025 (M mL)
    Table Global Insulin Glargine Sales Market Share Forecast by Product 2019-2025
    Table Global Insulin Glargine Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Insulin Glargine Revenue Market Share Forecast by Product 2019-2025
    Table Global Insulin Glargine Sales Forecast by End User 2019-2025 (M mL)
    Table Global Insulin Glargine Sales Market Share Forecast by End User 2019-2025
    Figure North America Insulin Glargine Sales Growth Rate Forecast (2019-2025) (M mL)
    Figure North America Insulin Glargine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Insulin Glargine Sales Growth Rate Forecast (2019-2025) (M mL)
    Figure Europe Insulin Glargine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Insulin Glargine Sales Growth Rate Forecast (2019-2025) (M mL)
    Figure Asia Pacific Insulin Glargine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Insulin Glargine Sales Growth Rate Forecast (2019-2025) (M mL)
    Figure Central & South America Insulin Glargine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Insulin Glargine Sales Growth Rate Forecast (2019-2025) (M mL)
    Figure Middle East and Africa Insulin Glargine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Insulin Glargine Value Chain
    Table Insulin Glargine Customers List
    Table Insulin Glargine Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global Type 1 Diabetes Treatment Market Size Status and Forecast 2021 2027
Global Type-1 Diabetes Treatment Market Size, Status and Forecast 2021-2027

Failure to produce insulin is the cause of this type of diabetes.Market Analysis and Insights Global Type1 Diabetes Treatment MarketThe global Type1 Diabetes Treatment market size is projected to reach US 7034.4 million by 2027 from US 5020 million in 2020 at a CAGR of 4.5 during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Type1 Diabetes Treatment market to help players in achieving a strong market position.

120 Pages
Type: Report
Code: QYRE-Auto-18I2851
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Self Blood Glucose Monitoring Market Size Status and Forecast 2021 2027
Global Self Blood Glucose Monitoring Market Size, Status and Forecast 2021-2027

Self Blood Glucose Monitoring is an approach whereby people withdiabetesmeasure theirblood sugarglycemia themselves using a glycemic reader.Market Analysis and Insights Global Self Blood Glucose Monitoring MarketThe global Self Blood Glucose Monitoring market size is projected to reach US 18050 million by 2027 from US 11100 million in 2020 at a CAGR of 6.7 during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Self Blood Glucose Monitoring market to help players in achieving a strong market position.

120 Pages
Type: Report
Code: QYRE-Auto-21E1004
Sat Jul 17 00:00:00 UTC 2021

Add to Cart

Global Pituitary Cancer Market Size Status and Forecast 2021 2027
Global Pituitary Cancer Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-16T5976
Fri Jul 16 00:00:00 UTC 2021

Add to Cart

Global Diabetic Assay Market Size Status and Forecast 2021 2027
Global Diabetic Assay Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-37T1733
Mon Jul 12 00:00:00 UTC 2021

Add to Cart